<prompt> Answer this question truthfullyWhich antitumor monoclonal antibody is associated with an increased risk of bleeding and thromboembolism?  <response>: <reason> Bevacizumab is the antitumor monoclonal antibody associated with an increased risk of bleeding and thromboembolism. 